UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000034175
Receipt number R000038846
Scientific Title Telemedicine using smart glasses, wearable computer glasses, in patients with Parkinson's disease.
Date of disclosure of the study information 2018/09/18
Last modified on 2018/09/18 00:43:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Telemedicine using smart glasses, wearable computer glasses, in patients with Parkinson's disease.

Acronym

Telemedicine using smart glasses, wearable computer glasses, in patients with Parkinson's disease.

Scientific Title

Telemedicine using smart glasses, wearable computer glasses, in patients with Parkinson's disease.

Scientific Title:Acronym

Telemedicine using smart glasses, wearable computer glasses, in patients with Parkinson's disease.

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will test the usefulness of telemedicine (D to D to P) by smart glasses for patients with Parkinson's disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

MDS-UPDRS

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

A local doctor (non-specialist) carries out regular medical examination for patients who live in a detached island diagnosed Parkinson's disease once a month for 6 months.This period is as the control period, and virtual specialized outpatient is held using smart glass followed by a neurologist in university hospital once a month for 6 months.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who satisfy all the following criteria are targeted.
1. The patient who desire a virtual expert clinic and can visit one year.
2. The patient who satisfy the criteria; by the Ministry of Health, Labor and Welfare Specific Disease Research Group, UK Parkinson 's Disease Society Brain Bank Criteria (1992), or diagnostic criteria of Movement Disorder Society (MDS).

3. Outpatient.
4. 20 years old or over.
5. Gender does not matter.
6. The patient who consent to join this research with full understanding.

Key exclusion criteria

Patients applicable to even one of the following are excluded as subjects.
1. The patient who is in the outpatient specialized in neurology
2. The patients who do not wish to have a virtual nerve specialized clinic
3. The patients who were judged inappropriate as researchers

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Teiichirou Miyazaki

Organization

Nagasaki University Hospital

Division name

Department of Neurology and Strokology

Zip code


Address

1-7-1, Sakamoto, Nagasaki City, Nagasaki, Japan

TEL

095-819-7200

Email

teacomet@hotmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Teiichirou Miyazaki

Organization

Nagasaki University Hospital

Division name

Department of Neurology and Strokology

Zip code


Address

1-7-1, Sakamoto, Nagasaki City, Nagasaki, Japan

TEL

095-819-7200

Homepage URL


Email

teacomet@hotmail.com


Sponsor or person

Institute

Nagasaki University Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2018 Year 09 Month 10 Day

Date of IRB


Anticipated trial start date

2018 Year 09 Month 18 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 18 Day

Last modified on

2018 Year 09 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038846


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name